disopyramide, (s)-isomer has been researched along with flunisolide in 1 studies
Studies (disopyramide, (s)-isomer) | Trials (disopyramide, (s)-isomer) | Recent Studies (post-2010) (disopyramide, (s)-isomer) | Studies (flunisolide) | Trials (flunisolide) | Recent Studies (post-2010) (flunisolide) |
---|---|---|---|---|---|
5 | 0 | 0 | 286 | 125 | 32 |
Protein | Taxonomy | disopyramide, (s)-isomer (IC50) | flunisolide (IC50) |
---|---|---|---|
Glucocorticoid receptor | Homo sapiens (human) | 0.0053 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.0053 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.0053 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.0053 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.0053 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
1 other study(ies) available for disopyramide, (s)-isomer and flunisolide
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |